Product Information
NAFTIFINE HCL 2% CREAM is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $2.1891 per GM under NDC 51672136803. Its NADAC has been published 542 times since May 18, 2016.
FDA first approved this application on Jan 6, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/g
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672136803
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
NAFTIFINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206901FDA Approved
1/6/2016
TE Code
AB
On Market Since
1/6/2016
Pharmacological Classes
Price Statistics
The NADAC for NAFTIFINE HCL 2% CREAM has been published 542 times since May 18, 2016, and over the history we have for it it has declined 63.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1891 per GM |
|---|---|
| All-time high | $6.7461 (Nov 16, 2016) |
| All-time low | $1.1856 (Jan 19, 2022) |
| 52-week high | $2.2568 |
| 52-week low | $2.0370 |
| Median price | $4.0565 |
| Average price | $3.8803 |
| Largest weekly change | +101.1% (Jul 20, 2022) |
| Weeks tracked | 542 |
| Tracking since | May 18, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naftifine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Allylamine Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NAFTIFINE HCL 2% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for NAFTIFINE HCL 2% CREAM, manufactured by Sun Pharmaceutical Industries Inc., is $2.1891 per GM (NDC 51672136803), effective Sep 30, 2026.
How has the price of NAFTIFINE HCL 2% CREAM changed over time?
Over the history we have for it, the NADAC for NAFTIFINE HCL 2% CREAM has declined 63.7%. It has been tracked across 542 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for NAFTIFINE HCL 2% CREAM?
Since May 18, 2016, the NADAC for NAFTIFINE HCL 2% CREAM has ranged from a low of $1.1856 (Jan 19, 2022) to a high of $6.7461 (Nov 16, 2016), with a median of $4.0565 per GM.
Are there cheaper alternatives to NAFTIFINE HCL 2% CREAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NAFTIFINE HCL 2% CREAM, is $1.8061 per GM — about 17% below NAFTIFINE HCL 2% CREAM.
Who manufactures NAFTIFINE HCL 2% CREAM?
NAFTIFINE HCL 2% CREAM (NDC 51672136803) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.